Document is current
Any future updates will be listed below
-
Authors
Zugasti, Ines
Lopez-Guerra, Monica
Castaño-Díez, Sandra
Esteban, Daniel
Avendaño, Alejandro
Pomares, Helena
Perez, Ana
García-Ávila, Sara
Conejo, Irene Padilla
de la Fuente Montes, Cristina
Martínez-Roca, Alexandra
Merchán, Beatriz
Jiménez-Vicente, Carlos
Guijarro, Francesca
Álamo, Jose Ramón
Cortes-Bullich, Albert
Torrecillas, Victor
Mont, Lucia
Carcelero, Esther
Riu, Gisela
Zamora, Lurdes
Bargay, Joan
Triguero, Ana
Suarez-Lledó, Maria
Salas, Maria Queralt
López-Cadenas, Felix
Ramos, Fernando
Xicoy, Blanca
Valcárcel, David
Arnan, Montserrat
Martínez, Carmen
Rovira, Montserrat
Fernández-Avilés, Francesc
Díez-Campelo, Maria
Esteve, Jordi
Díaz-Beyá, Marina
-
Funding
Funding for this research was provided by:
Convocatòria d’Intensificació Interna per als professionals de l’HCB 2023 Emili-Letang
Instituto de Salud Carlos III (PI22/01660)
Instituto de Salud Carlos III (PI22/01660)
- License Information
-
More Information
Article History
Received: 26 December 2024
Accepted: 31 March 2025
First Online: 26 April 2025
Declarations
:
: The authors declare no competing financial interests. JE: consultancy-honoraria (Abbvie, Novartis, Astellas, Jazz Pharmaceuticals, BMS-Celgene, Pfizer, Daiichi-Sankyo), research grants (Novartis, Jazz Pharmaceuticals); MD-B.: consultant or advisory role, travel grants or speaker (Bristol Myers Squibb-Celgene, Abbvie, Astellas, JazzPharma, Takeda, Novartis). SC-D: travel grants from Novartis, Abbie, Jazz Pharmaceuticals. IZ: Travel grant from Jazz Pharmaceuticals. For the remaining authors, no conflicts of interest were declared. These organizations had no role in the design of the study; in the collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
